Form 144: 150,000 Common Shares Listed for Sale

150,000 shares of Common Stock are listed for sale under Rule 144 in a Form 144 notice dated 03/16/2026.

Rhea-AI Filing Summary

150,000 shares of Common Stock are listed for sale under Rule 144 in a Form 144 notice dated 03/16/2026. The filing shows an option grant date of 02/27/2017 and cash as the consideration method.

The document names Fidelity Brokerage Services LLC as broker and records a prior sale by Alane Barnes of 21,773 shares on 12/22/2025 for $166,563.45. The filing is a routine resale notice and does not state proceeds recipient beyond the broker listing.

Insights

Securities Compliance Specialist

Routine Rule 144 resale notice for 03/16/2026.

The filing lists 150,000 shares of Common Stock offered for sale under Rule 144 with an underlying option grant dated 02/27/2017. It names Fidelity Brokerage Services LLC as the brokerage intermediary and indicates cash as the consideration method.

Because this is a resale notice, the document is procedural; cash‑flow treatment to the issuer is not stated and timing/mechanism details beyond the broker listing are not provided in the excerpt.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 for BCRX report?

The Form 144 reports 150,000 shares of Common Stock listed for sale on 03/16/2026 under Rule 144. It notes an underlying option grant dated 02/27/2017 and lists Fidelity Brokerage Services LLC as broker.

Who is the broker named in the BCRX Form 144?

The filing names Fidelity Brokerage Services LLC at 900 Salem Street, Smithfield, RI as the broker. The broker is shown in connection with the 150,000 shares the notice lists for sale on 03/16/2026.

Does the Form 144 show any prior sales for BCRX insiders?

Yes. The filing records a prior sale by Alane Barnes of 21,773 shares on 12/22/2025 for $166,563.45. That prior sale is listed separately from the current 150,000 share notice.

What consideration method is listed on the BCRX filing?

The Form 144 indicates cash as the consideration method for the 150,000 shares listed on 03/16/2026. No additional details about proceeds distribution are provided in the excerpt.

Is the sale in the Form 144 primary issuance or resale for BCRX?

This is a resale notice under Rule 144, showing securities to be sold by a holder rather than a primary issuance. The filing ties the shares to an option grant dated 02/27/2017 and lists a broker for execution.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/16/2026 - 04:17 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001584348
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	BIOCRYST PHARMACEUTICALS INC
SEC File Number	000-23186
Address of Issuer	4505 EMPEROR BOULEVARD SUITE 200 DURHAM NORTH CAROLINA 27703
Phone	919-859-1302
Name of Person for Whose Account the Securities are To Be Sold	Barnes Alane P
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	150000	1372007.37	250800620	03/16/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/16/2026	Option Granted - 02/27/2017	Issuer			150000	03/16/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Alane Barnes 4505 Emperor Blvd. Suite 200 Durham NC 27703	Common	12/22/2025	21773	166563.45

144: Remarks and Signature

Remarks
Date of Notice	03/16/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/13/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Emily Navaro, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Alane Barnes.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)